Clinical trial

Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease

NCT00465959

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-04-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2007-04-01Date precision: month

Registry last updated2013-12-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

trospium chloride inhalation powder (TrIP)DRUG

PlaceboDRUG

Sponsors & collaborators

Endo USA Inc., a Keenova Therapeutics Companylead sponsor

Alkermes, Inc.collaborator

Mapped research locations

SpartanburgSouth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00465959 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.